HRC
TLSI icon

Hoertkorn Richard Charles’s TriSalus Life Sciences TLSI Stock Holding History

Hoertkorn Richard Charles’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.67K Hold
668
– – ﹤0.01% 66
2025
Q4 		$4.66K Hold
668
– – ﹤0.01% 69
2025
Q3 		$3.11K Hold
668
– – ﹤0.01% 71
2025
Q2 		$3.64K Hold
668
– – ﹤0.01% 70
2025
Q1 		$3.69K Hold
668
– – ﹤0.01% 71
2024
Q4 		$3.35K Hold
668
– – ﹤0.01% 73
2024
Q3 		$3.08K Hold
668
– – ﹤0.01% 74
2024
Q2 		$3.69K Hold
668
– – ﹤0.01% 74
2024
Q1 		$6.51K Hold
668
– – ﹤0.01% 70
2023
Q4 		$5.64K Buy
+668
New +$3.44K ﹤0.01% 72

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Hoertkorn Richard Charles's TLSI Position: Q1 2026 in Review

Hoertkorn Richard Charles held its TriSalus Life Sciences (TLSI) position steady in Q1 2026 at 668 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #66.

Hoertkorn Richard Charles first reported a position in TLSI in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.51K in Q1 2024. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Hoertkorn Richard Charles held 668 shares of TriSalus Life Sciences worth $2.67K as of Q1 2026.
  • Hoertkorn Richard Charles left its TriSalus Life Sciences share count unchanged in Q1 2026.
  • TriSalus Life Sciences made up ﹤0.01% of Hoertkorn Richard Charles's portfolio in Q1 2026, its #66 holding.
  • Hoertkorn Richard Charles first reported a position in TriSalus Life Sciences in Q4 2023 and has held it in 10 quarters since.
  • Hoertkorn Richard Charles's TriSalus Life Sciences position peaked at $6.51K in Q1 2024.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Hoertkorn Richard Charles's 13F filing for Q1 2026, filed 30 Apr 2026.